Trupanion (TRUP) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
The 2026 Annual Meeting is scheduled for June 10, 2026, with voting available online, by mail, phone, or in person with an admission ticket requested by May 14, 2026.
Proxy materials are primarily delivered electronically to reduce environmental impact and costs, with paper copies available upon request.
The agenda includes electing nine directors, ratifying the independent auditor, and an advisory vote on executive compensation.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors, ratifying Ernst & Young LLP as auditor for 2026, and approving executive compensation for 2025 on a non-binding basis.
Board recommends voting “FOR” all proposals.
Shareholder proposals for the 2027 meeting must be submitted between February 25 and March 27, 2027.
Board of directors and corporate governance
Board will be reduced to nine members; all nominees are listed with diverse backgrounds in finance, governance, animal health, and executive leadership.
Eight of ten current directors are independent under NASDAQ and SEC rules.
Board committees include audit, compensation, and nominating/governance, each with independent members and defined charters.
Lead Independent Director ensures effective governance and communication.
Board and committees met regularly in 2025, with high attendance and executive sessions held.
Latest events from Trupanion
- Q1 2026 revenue up 12% to $384M, AOI up 29%, and margins reached record highs.TRUP
Q1 20261 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.TRUP
Proxy filing27 Apr 2026 - Revenue up 12% to $1.44B, net income $19.4M, strong cash flow and subscription growth.TRUP
Q4 20259 Apr 2026 - Strong growth, data-driven innovation, and new products position the company for market expansion.TRUP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Low market penetration and strong recurring revenue signal major growth potential.TRUP
Investor presentation2 Mar 2026 - 2026 guidance highlights pricing-led growth, margin expansion, and broader customer acquisition.TRUP
BofA Securities Animal Health Summit26 Feb 2026 - Q2 2024 revenue up 16%, margins and cash flow improved, and pet retention remained strong.TRUP
Q2 20242 Feb 2026 - Margin expansion, strong retention, and capital surplus drive disciplined growth and innovation.TRUP
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Sustainable growth driven by vet channel, margin recovery, and international expansion.TRUP
Investor Day 202420 Jan 2026